0001209191-19-000963.txt : 20190103
0001209191-19-000963.hdr.sgml : 20190103
20190103162811
ACCESSION NUMBER: 0001209191-19-000963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULME ALLISON
CENTRAL INDEX KEY: 0001573886
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36054
FILM NUMBER: 19505917
MAIL ADDRESS:
STREET 1: C/O SOPHIRIS BIO INC., 1258 PROSPECT ST
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOPHIRIS BIO INC.
CENTRAL INDEX KEY: 0001563855
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1258 PROSPECT STREET
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-777-1760
MAIL ADDRESS:
STREET 1: 1258 PROSPECT STREET
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-31
0
0001563855
SOPHIRIS BIO INC.
SPHS
0001573886
HULME ALLISON
1258 PROSPECT STREET
LA JOLLA
CA
92037
1
1
0
0
Chief Operating Officer
Common Stock (Right to Buy)
0.83
2018-12-31
4
A
0
245000
0.00
A
2019-12-21
2028-12-30
Common Stock
245000
245000
D
33% of the shares subject to the option shall vest on December 21, 2019. The remainder shall vest monthly thereafter over the next two years until fully vested on December 21, 2021.
/s/ Peter Slover, Attorney-in-fact
2019-01-02